Диссертация (1174245), страница 22
Текст из файла (страница 22)
S. Nasreddine, N. A. Phillips, V.Bédirian, S. Charbonneau, V. Whitehead, I. Collin, J. L. Cummings, H. Chertkow // J.Am. Geriatr. Soc. – 2005. – Т. 53 – № 4 – P.695-699.199. Ning, A. Amyloid-β deposits lead to retinal degeneration in a mouse model ofAlzheimer disease / A. Ning, J.
Cui, E. To, K. H. Ashe, J. Matsubara // Invest.Ophthalmol. Vis. Sci. – 2008. – Т. 49 – № 11 – P. 5136-5143.200. Ohno-Matsui, K. Parallel findings in age-related macular degeneration andAlzheimer’s disease / K. Ohno-Matsui // Prog. Retin. Eye Res. – 2011. – Т. 30 – № 4 –P. 217-228.201. Organization W.H. Dementia: A Public Health Priority. Geneva: WHO, 2012/ W. H. Organization // Innov.
Radar Act. Heal. Ageing Heal. Wellbeing White Pap. ISBN– P. 978–991.202. World Health Organization. The world health report 2002: reducing risks,129promoting healthy life. – World Health Organization, 2002.203. World Health Organization. World Health Organization dementia: A publichealth priority. Geneva, Switzerland: World Health Organization; 2012.204. Pache, M. Colour vision deficiencies in Alzheimer’s disease / M.
Pache, C. H.W. Smeets, P. F. Gasio, E. Savaskan, J. Flammer, A. Wirz‐Justice, H. J. Kaiser // AgeAgeing – 2003. – Т. 32 – № 4 – P. 422-426.205. Paquet, C. Abnormal retinal thickness in patients with mild cognitiveimpairment and Alzheimer’s disease / C. Paquet, M. Boissonnot, F. Roger, P. Dighiero,R. Gil, J.
Hugon // Neurosci. Lett. – 2007. – Т. 420 – № 2 – P. 97–99.206. Parisi, V. Correlation between morphological and functional retinalimpairment in patients affected by ocular hypertension, glaucoma, demyelinating opticneuritis and Alzheimer’s disease/ V.Parisi// Taylor & Francis. - 2003. – T.65 - №1 - P.50–57.207. Parisi, V. Morphological and functional retinal impairment in Alzheimer’sdisease patients / V. Parisi, R.
Restuccia, F. Fattapposta, C. Mina, M. G. Bucci, F. Pierelli// Clin. Neurophysiol. – 2001. – Т. 112 – № 10 – P. 1860–1867.208. Parnell, M. Ocular manifestations of Alzheimer’s disease in animal models /M. Parnell, L. Guo, M. Abdi, M. F. Cordeiro // Int. J. Alzheimer’s Dis. – 2012. – Т. 12 №2 - P. 23-25.209. Patterson, C. Diagnosis and treatment of dementia: 1. Risk assessment andprimary prevention of Alzheimer disease / C. Patterson, J. W. Feightner, A.
Garcia, G.Y. R. Hsiung, C. MacKnight, A. D. Sadovnick // Int. J. Alzheimer’s Dis. – 2008. – Т.178 – № 5 – P. 548–556.210. Patton, N. Retinal vascular image analysis as a potential screening tool forcerebrovascular disease: a rationale based on homology between cerebral and retinalmicrovasculatures / N. Patton, T. Aslam, T. MacGillivray, A. Pattie, I. J.
Deary, B.Dhillon // J. Anat. – 2005. – Т. 206 – № 4 – P. 319-328.130211. Paul, R.H.Vascular dementia: cerebrovascular mechanisms and clinicalmanagement / R. H. Paul// Springer Science. - 2005. - T.45 - №2 - P.456-459.212. Pelletier, A.A. Prevalence of glaucoma in hospitalized older adults withAlzheimer’s disease / A.A. Pelletier, M.-È. Théorêt, T. Boutin, M.-J. Kergoat, F.Massoud, J. Latour, C. Chayer, H. Kergoat // Can. J. Neurol. Sci. – 2014. – Т. 41 – № 2– P. 206-209.213.
Pendlebury, S.T. Prevalence, incidence, and factors associated with pre-strokeand post-stroke dementia: a systematic review and meta-analysis / S. T. Pendlebury, P.M. Rothwell // Lancet Neurol. – 2009. – Т. 8 – № 11 – P. 1006-1018.214. Pérez, C.G. High frequency of cognitive dysfunction before stroke amongolder people / C. G. Pérez, M.
Sävborg, U. Påhlman, M. Cederfeldt, E. Knopp, A.Nordlund, R. Åstrand, A. Wallin, K. Fröjd, H. Wijk // Int. J. Geriatr. Psychiatry – 2011.– Т. 26 – № 6 – P. 622-629.215. Polo, V. Reliability and validity of Cirrus and Spectralis optical coherencetomography for detecting retinal atrophy in Alzheimer’s disease / V. Polo, E. GarciaMartin, M.
P. Bambo, J. Pinilla, J. M. Larrosa, M. Satue, S. Otin, L. E. Pablo // Eye. –2014. – Т. 28 – № 6 – P. 680.216. Prettyman, R. Altered pupillary size and darkness and light reflexes inAlzheimer’s disease. / R. Prettyman, P. Bitsios, E. Szabadi // J. Neurol. Neurosurg.Psychiatry. – 1997. – Т. 62 – № 6 – P. 665-668.217. Ransmayr, G. Difficulties in the clinical diagnosis of vascular dementia anddementia of the Alzheimer type—comparison of clinical classifications Springer, 1998.– T. 12 - №2 - P. 79–90.218. Reitz, C.
Prestroke cognitive performance, incident stroke, and risk ofdementia: the Rotterdam Study / C. Reitz, M. J. Bos, A. Hofman, P. J. Koudstaal, M. M.B. Breteler // Stroke. – 2008. – Т. 39 – № 1 – P. 36–41.219. Rizzi, L. Global epidemiology of dementia: Alzheimer’s and vascular types /131L. Rizzi, I. Rosset, M. Roriz-Cruz // Biomed Res.
Int. – 2014. – Т.14 - №3 - P. 21-24.220. Rogaev, E.I. Familial Alzheimer’s disease in kindreds with missensemutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene / E.I. Rogaev, R. Sherrington, E. A. Rogaeva, G.
Levesque, M. Ikeda, Y. Liang, H. Chi, C.Lin, K. Holman, T. Tsuda // Nature. – 1995. – Т. 3 – № 65 – P. 775.221. Roman, G. V Vascular dementia: NINDS-AIREN diagnostic criteria / G. VRoman // New concepts Vasc. dementia. A. Culebras, J. Matias Guiu, G. Rom. (eds).Barcelona Prous Sci. Publ. – 1993. – T. 4 - № 13 - P. 1-9.222. Sadun, A.A. Optical Coherence Tomography in Alzheimer’s Disease: AMeta-Analysis / A. A. Sadun, G. Coppola, F. Martelli, V. Parisi, P. Barboni, G. Manni,F.
Pierelli, A. Di Renzo, L. Ziccardi, A. Fadda // Plos one – 2015. – Т. 10 – № 8 – P. 50.223. Seshadri, S. The lifetime risk of stroke: estimates from the Framingham Study/ S. Seshadri, A. Beiser, M. Kelly-Hayes, C. S. Kase, R. Au, W. B. Kannel, P. A. Wolf //Stroke. – 2006. – Т. 37 – № 2 – P. 345-350.224. Shi, Z. The utilization of retinal nerve fiber layer thickness to predict cognitivedeterioration / Z. Shi, Y. Zhu, M. Wang, Y.
Wu, J. Cao, C. Li, Z. Xie, Y. Shen // J.Alzheimer’s Dis. – 2016. – Т. 49 – № 2 – P. 399-315.225.Skoog, I. Epidemiology of vascular dementia in Europe/ I. Skoog// J.Alzheimer’s Dis. - 2019. – T.78 - №6 - P.54–68.226. Skoog, I. Vascular factors and Alzheimer disease. / I. Skoog, R. N. Kalaria,M. M. Breteler // Alzheimer Dis. Assoc. Disord. – 1999. – Т. 13 – №2 - P. 6-14.227. Sperling, R.A. Toward defining the preclinical stages of Alzheimer’s disease:Recommendations from the National Institute on Aging-Alzheimer’s Associationworkgroups on diagnostic guidelines for Alzheimer’s disease / R. A.
Sperling, P. S.Aisen, L. A. Beckett, D. A. Bennett, S. Craft, A. M. Fagan, T. Iwatsubo, C. R. Jack Jr, J.Kaye, T. J. Montine // Alzheimer’s Dement. – 2011. – Т. 7 – № 3 – P. 280-292.228. Stern, Y. Cognitive reserve / Y. Stern // Neuropsychologia. – 2009. – Т. 47 –132№ 10 – P. 2015-2028.229. Sunderland, T. Clock drawing in Alzheimer’s disease: a novel measure ofdementia severity / T. Sunderland, J. L. Hill, A. M. Mellow, B. A.
Lawlor, J.Gundersheimer, P. A. Newhouse, J. H. Grafman // J. Am. Geriatr. Soc. – 1989. – Т. 37 –№ 8 – P. 725-729.230. Sung, K.R. Effects of age on optical coherence tomography measurements ofhealthy retinal nerve fiber layer, macula, and optic nerve head / K. R. Sung, G. Wollstein,R. A. Bilonick, K. A. Townsend, H. Ishikawa, L. Kagemann, R.
J. Noecker, J. G.Fujimoto, J. S. Schuman // Ophthalmology. – 2009. – Т. 116 – № 6 – P. 1119-1124.231. Takagi, A. Sensitive pupil response of early-onset Аlzheimer’s patients to adilute mixture of cholinergic antagonist and α-Adrenergic stimulant / A. Takagi, M.Miyao, S. Ishihara, H. Sakakibara, T. Kondo, H. Toyoshima, K.
Kono, A. Iguchi //Environ. Health Prev. Med. – 1999. – Т. 4 – № 1 – P. 49-53.232. Tamura, H. High frequency of open-angle glaucoma in Japanese patients withAlzheimer’s disease / H. Tamura, H. Kawakami, T. Kanamoto, T. Kato, T. Yokoyama,K. Sasaki, Y. Izumi, M. Matsumoto, H. K. Mishima // J. Neurol.
Sci. – 2006. – Т. 246 –№ 1– P. 79-83.233. Tapiola, T. Cerebrospinal fluid β-amyloid 42 and tau proteins as biomarkersof Alzheimer-type pathologic changes in the brain / T. Tapiola, I. Alafuzoff, S.-K.Herukka, L. Parkkinen, P. Hartikainen, H. Soininen, T. Pirttilä // Arch. Neurol. – 2009. –Т.
66 – № 3 – P. 382-389.234. Tatemichi, T.K. Risk of dementia after stroke in a hospitalized cohort: resultsof a longitudinal study / T. K. Tatemichi, M. Paik, E. Bagiella, D. W. Desmond, Y. Stern,M. Sano, W. A. Hauser, R. Mayeux // Neurology. – 1994. – Т. 44 – № 10 – P. 1885.235. Thomson, K.L. A systematic review and meta-analysis of retinal nerve fiberlayer change in dementia, using optical coherence tomography / K.
L. Thomson, J. M.Yeo, B. Waddell, J. R. Cameron, S. Pal // Alzheimer’s Dement. Diagnosis, Assess. Dis.133Monit. – 2015. – Т. 1 – № 2 – P. 136-143.236. Trick, G.L. Visual field loss in senile dementia of the Alzheimer’s type / G.L. Trick, L. R. Trick, P. Morris, M. Wolf // Neurology. – 1995. – Т. 45 – № 1 – P. 68–74.237. Tuomilehto, J. Diabetes mellitus as a risk factor for death from stroke:prospective study of the middle-aged Finnish population / J. Tuomilehto, D.
Rastenyt�,P. Jousilahti, C. Sarti, E. Vartiainen // Stroke – 1996. – Т. 27 – № 2 – P. 210-215.238. Turski, G.N. Retinal imaging of the macula and optic disc inneurodegenerative diseases / G. N. Turski, S. Schmitz-Valckenberg, F. G. Holz, R. P.Finger // Der Ophthalmol. Zeitschrift der Dtsch. Ophthalmol. Gesellschaft – 2017. – Т.14– № 2 – P.114-119.239.
Valenti, D.A. Alzheimer’s disease and glaucoma: imaging the biomarkers ofneurodegenerative disease / D. A. Valenti // Int. J. Alzheimer’s Dis. – 2010. – Т. 16 - №4- P. 5-9.240. Walsh, D.M. The oligomerization of amyloid β-protein begins intracellularlyin cells derived from human brain / D. M. Walsh, B. P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
